Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 556 to 570 of 1300 results for heart OR cardi* OR arrythmia

  1. Indications for interventions – stress testing or echocardiography: What is the prognostic value of severe mitral regurgitation unmasked on exercise echocardiography in adults with symptomatic non‑severe mitral regurgitation at rest?

    applicable) Source guidance details Comes from guidance Heart valve disease presenting in adults: investigation and management Number

    Research recommendation
    Published
    16 December 2021

  2. Repeat interventions: What is the clinical and cost effectiveness of transcatheter intervention compared with surgical redo intervention for adults with failing biological prosthetic aortic valves when either procedure is suitable?

    applicable) Source guidance details Comes from guidance Heart valve disease presenting in adults: investigation and management Number

    Research recommendation
    Published
    16 December 2021

  3. Repeat interventions: What is the clinical and cost effectiveness of transcatheter intervention compared with surgical redo intervention for adults with failing biological prosthetic mitral valves when either procedure is suitable?

    applicable) Source guidance details Comes from guidance Heart valve disease presenting in adults: investigation and management Number

    Research recommendation
    Published
    16 December 2021

  4. Anticoagulation and antiplatelet therapy: What is the clinical and cost effectiveness of single or dual antiplatelet therapies or anticoagulants compared with placebo after transcatheter or surgical valve replacement (implantation) with biological prosthesis and after valve repair?

    applicable) Source guidance details Comes from guidance Heart valve disease presenting in adults: investigation and management Number

    Research recommendation
    Published
    16 December 2021

  5. Indications for interventions – global longitudinal strain: In adults with asymptomatic, severe aortic regurgitation or mitral regurgitation what is the prognostic value and cost effectiveness of B‑type natriuretic peptide (BNP) to assess the need for intervention?

    applicable) Source guidance details Comes from guidance Heart valve disease presenting in adults: investigation and management Number

    Research recommendation
    Published
    16 December 2021

  6. Digitally enabled therapies for adults with anxiety disorders: early value assessment (HTG676)

    Early value assessment (EVA) guidance on digitally enabled therapies for adults with anxiety disorders.

    HealthTech guidance
    Last updated
    14 December 2023
    View recommendations

    Sections for HTG676

  7. Artificial intelligence (AI)-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images (HTG687)

    Evidence-based recommendations on artificial intelligence (AI)-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images.

    HealthTech guidance
    Published
    5 July 2023
    View recommendations

    Sections for HTG687

  8. gammaCore for cluster headache (HTG533)

    Evidence-based recommendations on gammaCore for cluster headache.

    HealthTech guidance
    Published
    3 December 2019
    View recommendations

    Sections for HTG533

  9. Caplacizumab with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpura (TA667)

    Evidence-based recommendations on caplacizumab (Cablivi) with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpura in adults, and in young people aged 12 years and over who weigh at least 40 kg.

    Technology appraisal guidance
    Published
    16 December 2020
    View recommendations

    Sections for TA667

  10. Irreversible electroporation for treating pancreatic cancer (IPG579)

    Evidence-based recommendations on irreversible electroporation for treating pancreatic cancer. This involves inserting special needles into the tumour in the pancreas and using short electrical pulses to destroy the cancer cells.

    Interventional procedures guidance
    Published
    3 May 2017
    View recommendations

    Sections for IPG579

  11. Chronic heart failure: Management of chronic heart failure in adults in primary and secondary care (CG5)

    This guideline has been updated and replaced by NICE guideline CG108.

    Clinical guideline
    Published
    23 July 2003

  12. Is obesity an independent risk factor for perinatal morbidity and mortality?

    explanatory notes(if applicable) It is more difficult to monitor fetal heart rate, uterine contractions and fetal position in women who...

    Research recommendation
    Published
    16 August 2019

  13. Semaglutide for preventing major cardiovascular events in people with cardiovascular disease and overweight or obesity [ID6441]

    In development Reference number: GID-TA11544 Expected publication date:  14 May 2026

    Technology appraisal guidance
    In development

  14. Aficamten for treating symptomatic obstructive hypertrophic cardiomyopathy ID6575

    In development Reference number: GID-TA11742 Expected publication date: TBC

    Technology appraisal guidance
    In development

  15. Leadless cardiac pacemaker implantation for bradyarrhythmias

    In development Reference number: GID-IPG10340 Expected publication date:  25 February 2026

    Interventional procedures guidance
    In development